Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Early response to stapokibart predicts long-term efficacy in patients with chronic rhinosinusitis with nasal polyps].

Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology head and neck surgery·2026
Same author

[A case of chronic rhinosinusitis with nasal polyp with comorbid respiratory epithelial adenomatoid hamartoma with poor response to biologics].

Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology head and neck surgery·2026
Same author

Dual repression of OsSnRK1β1A by the deubiquitinase OsOTUB1 orchestrates energy metabolism and grain yield in rice.

Molecular plant·2026
Same author

A domestication gene links plant architecture and nitrogen metabolism to enhance yield in foxtail millet.

Nature communications·2026
Same author

Recent advancements in textile-based flexible electronics: a comprehensive review.

Nanoscale·2026
Same author

Natural and evolved membrane-associated accessory proteins differentially engage SNARE machinery for AAV egress.

Journal of virology·2026

Related Experiment Video

Updated: Jul 14, 2025

High-Efficiency Transduction of Liver Cancer Cells by Recombinant Adeno-Associated Virus Serotype 3 Vectors
19:02

High-Efficiency Transduction of Liver Cancer Cells by Recombinant Adeno-Associated Virus Serotype 3 Vectors

Published on: March 22, 2011

13.3K

Redirecting AAV vectors to extrahepatic tissues.

Aravind Asokan1, Shen Shen2

  • 1Department of Surgery, Duke University School of Medicine, Durham, NC, USA; Department of Molecular Genetics & Microbiology, Duke University School of Medicine, Durham, NC, USA; Department of Biomedical Engineering, Duke University, Durham, NC, USA.

Molecular Therapy : the Journal of the American Society of Gene Therapy
|October 8, 2023
PubMed
Summary

New adeno-associated viral (AAV) vectors are engineered to reduce liver uptake, improving gene therapy safety and efficacy for extrahepatic tissues like the brain and muscles.

Keywords:
adeno-associated virusadverse eventsbiodistributioncapsidextrahepaticgene deliverygene transferliver-de-targetingsafetytoxicitytropismvector engineering

More Related Videos

Production and Titering of Recombinant Adeno-associated Viral Vectors
08:35

Production and Titering of Recombinant Adeno-associated Viral Vectors

Published on: November 27, 2011

61.7K
Efficient Gene Knockdown in the Liver via Intrasplenic Injection of Adeno-Associated Virus Serotype 8 (AAV8)-Delivered Small Hairpin RNA
04:26

Efficient Gene Knockdown in the Liver via Intrasplenic Injection of Adeno-Associated Virus Serotype 8 (AAV8)-Delivered Small Hairpin RNA

Published on: November 1, 2024

391

Related Experiment Videos

Last Updated: Jul 14, 2025

High-Efficiency Transduction of Liver Cancer Cells by Recombinant Adeno-Associated Virus Serotype 3 Vectors
19:02

High-Efficiency Transduction of Liver Cancer Cells by Recombinant Adeno-Associated Virus Serotype 3 Vectors

Published on: March 22, 2011

13.3K
Production and Titering of Recombinant Adeno-associated Viral Vectors
08:35

Production and Titering of Recombinant Adeno-associated Viral Vectors

Published on: November 27, 2011

61.7K
Efficient Gene Knockdown in the Liver via Intrasplenic Injection of Adeno-Associated Virus Serotype 8 (AAV8)-Delivered Small Hairpin RNA
04:26

Efficient Gene Knockdown in the Liver via Intrasplenic Injection of Adeno-Associated Virus Serotype 8 (AAV8)-Delivered Small Hairpin RNA

Published on: November 1, 2024

391

Area of Science:

  • Gene therapy
  • Viral vector technology
  • Molecular biology

Background:

  • Recombinant adeno-associated viral (AAV) vectors are standard for in vivo gene therapy delivery.
  • High liver uptake of AAV vectors causes dose-limiting toxicity, hindering extrahepatic gene delivery.
  • Advances in understanding AAV biology enable the development of improved vector systems.

Purpose of the Study:

  • To introduce next-generation AAV vector candidates engineered for reduced liver targeting.
  • To explore the potential of these novel vectors for enhanced extrahepatic gene delivery.
  • To improve the safety profile of systemic gene therapy.

Main Methods:

  • Engineering of liver-de-targeted AAV capsids.
  • Evaluation of AAV vector tropism and biodistribution.
  • Assessment of gene expression in cardiovascular, musculoskeletal, and neurological tissues.

Main Results:

  • Novel AAV capsids demonstrate reduced preferential uptake by the liver.
  • Successful gene delivery to target extrahepatic tissues was achieved.
  • Improved safety profiles were observed compared to conventional AAV vectors.

Conclusions:

  • Engineered liver-de-targeted AAV vectors represent a promising advancement for systemic gene therapy.
  • These next-generation vectors offer potential for safer and more effective treatment of diseases affecting cardiovascular, musculoskeletal, and neurological systems.
  • Further development of these vectors could overcome current limitations in extrahepatic gene delivery.